GUOGANG GROUP
From October 16 to 18, 2025, the 67th China International Pharmaceutical Machinery Expo (CIPM) was grandly held at the Qingdao World Expo City. As an international exhibition endorsed by the Ministry of Commerce, this edition of the expo featured 200,000 square meters of exhibition space, 1,306 exhibitors from over 20 countries and regions, and nearly 80,000 professional visitors from home and abroad, once again solidifying its industry reputation as "the premier pharmaceutical machinery exhibition in the Asia-Pacific region." Shandong Guogang Commercial Group Huangdao Branch organized employee representatives to attend the event, gaining in-depth insights into industry trends and precisely connecting with high-quality resources to accumulate new momentum for the company's high-quality development in the pharmaceutical equipment sector.
This edition of CIPM featured exhibits spanning nine core sectors, including API equipment and pharmaceutical machinery, providing a comprehensive display of the entire industry chain. Nearly 100 professional forums and technical exchange sessions held concurrently focused on industry hotspots and innovation trends. During the event, the branch company representatives prioritized three key trends: biopharmaceutical equipment, intelligent and digital transformation, and the integration of global and local strategies.
In the 10,000-square-meter biopharmaceutical zone, cutting-edge technologies such as cell therapy and gene editing were dynamically showcased, while topics like AI-optimized fermentation processes sparked extensive industry discussion. Exhibits such as Maiben's "unmanned equipment + digital services" and Syntegon's intelligent production lines highlighted digitalization as an essential direction for pharmaceutical enterprises. The number of international visitors increased by nearly 80% year-on-year, with strong procurement demand from countries along the Belt and Road initiative, demonstrating effective alignment between global technologies and regional market needs.
This participation yielded substantial outcomes for the branch company. On one hand, it facilitated precise connections with over 30 potential clients, 40% of whom were overseas customers, focusing on customized needs for API reaction equipment and packaging production lines. Engagements with companies such as CR Double Crane and Malaysia Zhongfa Pharmaceutical Patch Group clarified the direction for product optimization through integrated "equipment + process + compliance consulting" services. On the other hand, benchmarking against industry leaders like Kӧrber and Uhlmann provided a clear recognition of gaps in high-end technology and comprehensive digital service chains, while also revealing the cost-effectiveness advantages and customized responsiveness of domestic enterprises in segments like traditional Chinese medicine processing machinery, identifying potential breakthroughs for niche market penetration. Furthermore, participation in industry forums enabled the branch to accurately grasp market trends driven by upgraded GMP certification and tightening environmental policies, such as the growing demand for "green equipment" and "compliance-oriented solutions," thereby providing policy and market foundations for future R&D directions.
The CIPM participation was not merely an observational journey to the industry forefront, but also a networking expedition for resource integration and an empowering experience for self-improvement. Seizing this exhibition as a strategic opportunity, Shandong Guogang Commercial Group Huangdao Branch will closely align with the industry's development direction of "high-end, intelligent, and green" transformation. By focusing on clients' core needs and strengthening technological breakthroughs and service upgrades, the company is committed to driving momentum in the localization of pharmaceutical equipment and contributing Guogang's strength to the industry's high-quality development.
